Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
May 5, 2025
Ensuring oxygen access is essential to achieving health for all
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. The looming antibiotic emergency and why the time for global action is now
    PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  2. PATH part of $12.7M GHIT Fund initiative for malaria, NTDs research.
    PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
  3. Opinion: GenAI for global health — the bear and the bull case
    Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  4. Life-saving advances in vaccines pave the way for healthier futures
    Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

950 Item s
950 Item s
    Date
    From
    To
  1. WHO resolution on strengthening diagnostics capacity key for global progress
    In a groundbreaking move toward advancing universal health coverage (UHC) and health equity, the World Health Organization recently passed a significant resolution on strengthening diagnostics capacity. This resolution, adopted during the 76th World Health Assembly on May 23, 2023, aims to address the challenges related to access, affordability, and quality of diagnostic tests.
    Published: June 2023
    Press Release
  2. Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria
    Over 80% of the 139,021 malaria cases reported in Brazil in 2021 were caused by P. vivax.Handheld test and single-dose medicine will support Brazil’s malaria elimination goal by improving patient adherence and ensuring patient safety.
    Published: June 2023
    Press Release
  3. PATH and KAUST join forces to address public health challenges in the Middle East and globally
    The partnership seeks to leverage expertise in vaccine development, digital health systems, and biobanking to advance global health equity and foster innovative solutions in Saudi Arabia and beyond.
    Published: June 2023
    Press Release
  4. Landmark oxygen resolution adopted by WHO Member States
    Resolution urges action to sustain gains and drive progress toward reliable and sustained oxygen access for all
    Published: May 2023
    Press Release
  5. Serum Institute's ACWYX vaccine candidate demonstrates strong safety and immunogenicity
    Results from a Phase 3 clinical study of a pentavalent meningococcal meningitis vaccine candidate designed for use in the African meningitis belt demonstrate it to be safe, well tolerated, and capable of producing strong immune responses to all five serogroups.
    Published: May 2023
    Announcement
Previous
Next